Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

t of 2020. Other speakers include Soil Health Partnership Lead Scientist Maria Bowman, American Forest Foundation President and CEO Tom Martin, and Ecosystem Services Market Commission Executive Director Debbie Reed; 8:30 AM * POMED discussion on 'Mohammed bin Salman's Saudi Arabia' — 'Mohammed bin Salman's Saudi Arabia' Project o

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

t of 2020. Other speakers include Soil Health Partnership Lead Scientist Maria Bowman, American Forest Foundation President and CEO Tom Martin, and Ecosystem Services Market Commission Executive Director Debbie Reed; 8:30 AM • POMED discussion on 'Mohammed bin Salman's Saudi Arabia' - 'Mohammed bin Salman's Saudi Arabia' Project o

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

t of 2020. Other speakers include Soil Health Partnership Lead Scientist Maria Bowman, American Forest Foundation President and CEO Tom Martin, and Ecosystem Services Market Commission Executive Director Debbie Reed; 8:30 AM • POMED discussion on 'Mohammed bin Salman's Saudi Arabia' - `Mohammed bin Salman's Saudi Arabia' Project o